Top Tech Companies (764)
Don't see your company?
Create a company profile
www.psgconsults.com. Pharmaceutical Strategies Group (PSG) is the leading pharmacy intelligence and technology company providing cutting-edge drug cost-management solutions. Drawing on more than 20 years of pharmaceutical innovation and best practices experience, we deploy proprietary technology, industry intelligence, data-enabled services and the industry’s most trusted advisors to help our clients reduce costs, enhance revenue, and optimize health outcomes. We offer a robust and holistic array of services designed to help healthcare systems, health plans, large employers and multi-employer organizations respond to the complexities of the prescription drug market and address their most pressing pharmacy management challenges. As a trusted strategic partner to more than 300 clients, we serve as an independent advocate and technology resource to help maximize their investment in pharmaceuticals. Our client-centric approach has allowed us maintain a 99.9 percent retention rate while generating over $6 billion in savings for organizations representing more than 100 million lives. Backed by a laser focus on pharmacy and unparalleled leverage in the marketplace, we deliver unbiased and actionable insights powered by analytics that enable us to ask better questions, find better answers and deliver better results.
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 45 years, we have proudly helped our clients earn more than 85 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, integrated clinical data solutions, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning
ImprimisRx, based in San Diego, California, is a specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations. We are a rapidly growing company looking to add talented individuals to join our team to help us reach our goals. We have a unique business model and a dedicated group of extraordinary people focused on delivering novel, customizable medicines to physicians and patients TODAY at accessible prices. We believe in creating long-term relationships by being responsive and relevant and by consistently delivering value to our community of customers. Specifically with our employees, we focus on attracting, developing and retaining the best talent for our business, challenging our people, demonstrating a “can-do” attitude and fostering a collaborative and mutually supportive environment. For more information, please visit www.ImprimisRx.com.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,700 people across 41 countries.
Kaléo is dedicated to inventing, manufacturing & commercializing life-transforming products that protect and empower patients and families to live fuller, bolder lives
Denver Health is an integrated, efficient, high-quality academic health care system that is considered a model for the nation. The Denver Health system includes the Rocky Mountain Regional Level I Trauma Center, a 547-bed acute care medical center, Denver’s 911 emergency medical response system, 9 family health centers, 19 school-based health centers, the Rocky Mountain Poison and Drug Center, Public Health Institute at Denver Health and The Denver Health Foundation. As Colorado’s primary safety net institution, Denver Health is a mission-driven organization that has provided more than $3.3 billion in care for the uninsured in the last ten years. Denver Health is a leader in performance and quality improvements and remains financially secure, in part, due to its nationally recognized implementation of lean principles in healthcare. Denver Health is a major resource to the community, serving approximately 185,000 individuals and 67,000 children a year. Located just south of downtown Denver, Denver Health is just minutes away from many of the cultural and recreational activities Denver has to offer. We strongly support diversity in the workforce and Denver Health is an equal opportunity employer (EOE). “Denver Health is committed to provide equal treatment and equal employment opportunities to all applicants and employees. Denver Health is an equal opportunity employer of all individuals, including women, minorities, protected veterans and individuals with disabilities.” Visit the Denver Health CAREER CENTER: http://www.denverhealth.org/about-us/career-center
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
.jpeg)
.png)
As a premier, independently owned CDMO with over 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with us when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer our clients tailored and versatile solutions to help them bring their products to market so they can get to the patients who need them. (Simtra is a tradename of Baxter Oncology GmbH and Baxter Pharmaceutical LLC)
Vireo Health is a physician-led company dedicated to providing patients with best-in-class cannabis-based products and high quality care
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease
Obsidian Therapeutics is pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s programs apply our cytoDriveTM technology in cell and gene therapy products to control expression of proteins for enhanced therapeutic efficacy, including our lead program cytoTIL15 engineered to make TILs more effective for more patients. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need. Located in the heart of Cambridge with a new laboratory facility in Bedford, we’re proud of our diverse talented team and committed to cultivating an environment of inclusion where we strive to instill a strong sense of belonging, and support each Obsidianite to continuously learn and contribute their best work. We offer competitive salary and benefits, and potential for employee ownership through stock options
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
Expanesthetics develops general anesthetics and pain-relievers.
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Particle Sciences is a full-service CDMO focused on formulation and GMP/GLP production, analytic and bioanalytic services. We provide an integrated suite of drug development services aimed at minimizing the time and risks of drug development. We focus on semisolids, suspensions, particulates and drug/device products, with additional specialized capabilities in sterile products and highly potent compounds. As our name implies, we are expert in fine-particle and nanotechnology approaches and regularly deal with challenging API's. Particle Sciences provides contract drug development services and brings over two decades of expertise providing an efficient suite of preformulation, formulation, analytic and manufacturing services. A responsive and collaborative approach ensures that the objectives of all clients, large and small, are successfully met on time and on budget with the highest degree of quality. Through a full range of pharmaceutical formulation, analytic, and clinical manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution designed to minimize the time and risk between discovery and the clinic.
Your trusted health expert, PetMeds® is a publicly traded company (NASDAQ: PETS). We deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. We serve millions of satisfied customers nationwide from one location.
At Mendel.ai, our mission is to use our novel AI aided by clinical experts to streamline global oncology research by organizing real world data and automating clinical trials. We build software to solve problems at each stage of the clinical trial process, from feasibility to post-trial pharmacovigilance. We strive for excellency, to be authentic and original, and to make a difference by greeting our challenges head on. Please visit our website, mendel.ai, to learn more about our company, goals, and values. Website
